Juan, CA
Antonio Juan, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20140189255 | METHOD AND APPARATUS TO SHARE MODIFIED DATA WITHOUT WRITE-BACK IN A SHARED-MEMORY MANY-CORE SYSTEM - A cache-coherent device may include multiple caches and a cache coherency engine, which monitors whether there are more than one versions of a cache line stored in the caches and whether the version of the cache line in the caches is consistent with the version of the cache line stored in the memory. | 07-03-2014 |
Kevin Juan, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20080220826 | Controller and Method for Using a DC-DC Converter in a Mobile Handset - A controller enables the integration of a DC-DC converter in an amplitude modulation power control loop in a mobile handset. The controller includes an input conditioner and an event sensor. The input conditioner uses a peak detector to track the output of a regulator and responds to available baseband input signals. The event sensor controls a switch that connects the DC-DC converter to a battery in response to a bypass event. The controller bypasses the DC-DC-converter when a transmitter is not enabled. The DC-DC converter is enabled prior to a transmission burst. A target voltage is determined from a series of detected peak voltages from the output of the regulator. The controller commands the DC-DC converter to transition to the target voltage until the end of a transmission burst. | 09-11-2008 |
20120064953 | CONTROLLER AND METHOD FOR USING A DC-DC CONVERTER IN A MOBILE HANDSET - A controller enables the integration of a DC-DC converter in an amplitude modulation power control loop in a mobile handset. The controller includes an input conditioner and an event sensor. The input conditioner uses a peak detector to track the output of a regulator and responds to available baseband input signals. The event sensor controls a switch that connects the DC-DC converter to a battery in response to a bypass event. The controller bypasses the DC-DC-converter when a transmitter is not enabled. The DC-DC converter is enabled prior to a transmission burst. A target voltage is determined from a series of detected peak voltages from the output of the regulator. The controller commands the DC-DC converter to transition to the target voltage until the end of a transmission burst. | 03-15-2012 |
Landa Juan, Anaheim, CA US
Patent application number | Description | Published |
---|---|---|
20120061543 | ADJUSTABLE FLAT-PANEL DISPLAY MOUNT - An adjustable flat-panel display mount is described. The display mount includes a mounting plate for mounting with a surface, such as a wall. A front mount is included. The front mount is formed to attach with a television display and affix the television display with the display mount. A swing out apparatus is pivotally connected between the mounting plate and the front mount. The swing out apparatus includes a set of bars that, together with the mounting plate and front mount, form a four-bar linkage. The swing out apparatus is formed to swing the front mount between a retracted position and an extended position, such that motion from the retracted to extended position moves the front mount, and attached television display, out and down. | 03-15-2012 |
Steve Juan, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20080205438 | Multi-Bus Structure For Optimizing System Performance Of a Serial Buffer - A serial buffer having a parser and multiple parallel processing paths is provided. The parser receives incoming packets, determines the type of each packet, and then routes each packet to a processing path that corresponds with the determined packet type. Packet types may include blocking priority packets (which implement bus slave operations), non-blocking priority packets (which access on-chip resources of the serial buffer) and data packets (which implement bus master operations). Because the different packet types are processed on parallel processing paths, the processing of one packet type does not interfere with the processing of other packet types. As a result, blocking conditions within the serial buffer are minimized. | 08-28-2008 |
Todd Juan, Moorpark, CA US
Patent application number | Description | Published |
---|---|---|
20090053763 | Tumor endothelial marker 7-alpha molecules and uses thereof - The present invention provides Tumor Endothelial Marker 7α (TEM7α) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TEM7α polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TEM7α polypeptides. | 02-26-2009 |
Todd Juan, Newbury Park, CA US
Patent application number | Description | Published |
---|---|---|
20080293055 | K-ras mutations and anti-EGFr antibody therapy - The present application relates to K-ras mutations, to polynucleotides encoding mutant K-ras polypeptides, and to methods of identifying K-ras mutations. The present application also relates to methods of diagnosing cancer; and methods and kits for predicting the usefulness of anti-EGFr specific binding agents in the treatment of tumors. | 11-27-2008 |
20110003755 | Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof - The present invention provides Tumor Endothelial Marker 5α (TEM5α) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TEM5α polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, or prevention of diseases, disorders, and conditions associated with TEM5α polypeptides. | 01-06-2011 |
20110033472 | Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof - The present invention provides Tumor Endothelial Marker 5α (TEM5α) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TEM5α polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, or prevention of diseases, disorders, and conditions associated with TEM5α polypeptides. | 02-10-2011 |
20120237959 | TUMOR ENDOTHELIAL MARKER 5-ALPHA MOLECULES AND USES THEREOF - The present invention provides Tumor Endothelial Marker 5α (TEM5α) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TEM5α polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, or prevention of diseases, disorders, and conditions associated with TEM5α polypeptides. | 09-20-2012 |
20120264129 | K-ras Mutations and Anti-EGFr Antibody Therapy - The present application relates to K-ras mutations, to polynucleotides encoding mutant K-ras polypeptides, and to methods of identifying K-ras mutations. The present application also relates to methods of diagnosing cancer; and methods and kits for predicting the usefulness of anti-EGFr specific binding agents in the treatment of tumors. | 10-18-2012 |
20120328620 | EPIDERMALGROWTH FACTOR RECEPTOR MUTATIONS - Mutations of the epidermal growth factor receptor (EGFr), of phosphatidylinositol 3′-kinase (“PI3K”), and of B-Raf are described. Methods of treating tumors containing mutated EGFr with human monoclonal antibodies against EGFr are described. Methods and kits for ascertaining the presence of one or more mutant EGFr, mutant PI3K, and/or mutant B-Raf in a sample and for treating disorders or conditions related to the presence of mutant EGFr, mutant PI3K, and/or mutant B-Raf are also described. Methods of treating tumors containing mutant EGFr, mutant PI3K, and/or mutant B-Raf are also described. | 12-27-2012 |
Veronica Juan, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20110305712 | CTLA4 PROTEINS AND THEIR USES - The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses. | 12-15-2011 |
20130330338 | CTLA4 PROTEINS AND THEIR USES - The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses. | 12-12-2013 |
20150051158 | CTLA4 PROTEINS AND THEIR USES - The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses. | 02-19-2015 |
Veronica M. Juan, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20090175847 | HUMANIZED ANTIBODIES TO AB (20-42) GLOBULOMER AND USES THEREOF - The present invention relates to binding proteins and, in particular, humanized antibodies that may be used, for example, in the diagnosis, treatment and prevention of Alzheimer's Disease and related conditions. | 07-09-2009 |
20090232801 | Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof - The present invention relates to binding proteins and, in particular, humanized antibodies that may be used, for example, in the diagnosis, treatment and prevention of Alzheimer's Disease and related conditions. | 09-17-2009 |
Veronica M. Juan, Menlo, CA US
Patent application number | Description | Published |
---|---|---|
20140186377 | PROSTAGLANDIN E2 BINDING PROTEINS AND USES THEREOF - The present invention encompasses prostaglandin E | 07-03-2014 |
Ya-Huey Juan, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20140331070 | DYNAMICALLY ADJUSTING POWER DISTURBANCE HOLD UP TIMES - Power line disturbance hold up times are dynamically adjusted prior to the commencement of the power disturbance failover based on battery capacity of batteries in racks of the storage system as the batteries either fail, are repaired, or are added to the storage system having at least one uninterruptible power supply (UPS). | 11-06-2014 |